130 related articles for article (PubMed ID: 38056021)
1. A clinical marker-based modeling framework to preoperatively predict lymph node and vascular space involvement in endometrial cancer patients.
Miller HA; Tran A; LyBarger KS; Frieboes HB
Eur J Surg Oncol; 2024 Jan; 50(1):107309. PubMed ID: 38056021
[TBL] [Abstract][Full Text] [Related]
2. CA125 as a predictor of endometrial cancer lymphovascular space invasion and lymph node metastasis for risk stratification in the preoperative setting.
Shawn LyBarger K; Miller HA; Frieboes HB
Sci Rep; 2022 Nov; 12(1):19783. PubMed ID: 36396713
[TBL] [Abstract][Full Text] [Related]
3. Nomogram with potential clinical use to predict lymph node metastasis in endometrial cancer patients diagnosed incidentally by postoperative pathological assessment.
Taşkın S; Şükür YE; Varlı B; Koyuncu K; Seval MM; Ateş C; Yüksel S; Güngör M; Ortaç F
Arch Gynecol Obstet; 2017 Oct; 296(4):803-809. PubMed ID: 28762064
[TBL] [Abstract][Full Text] [Related]
4. Risk factors for pelvic lymph node metastasis in endometrial cancer.
Li Y; Cong P; Wang P; Peng C; Liu M; Sun G
Arch Gynecol Obstet; 2019 Oct; 300(4):1007-1013. PubMed ID: 31435773
[TBL] [Abstract][Full Text] [Related]
5. Risk factors for pelvic and para-aortic lymph node metastasis in non-endometrioid endometrial cancer.
Sun Y; Wang Y; Cheng X; Wu W; Liu Q; Chen X; Ren F
Eur J Surg Oncol; 2024 Apr; 50(4):108260. PubMed ID: 38484492
[TBL] [Abstract][Full Text] [Related]
6. Factor affecting lymph node metastasis in uterine papillary serous carcinomas: a retrospective analysis.
Tutkun Kilinc EC; Korkmaz V; Yalcin HR
J Obstet Gynaecol; 2022 Nov; 42(8):3725-3730. PubMed ID: 36927276
[TBL] [Abstract][Full Text] [Related]
7. Lymph node metastasis and pattern of recurrence in clinically early stage endometrial cancer with positive lymphovascular space invasion.
Mahdi H; Jernigan A; Nutter B; Michener C; Rose PG
J Gynecol Oncol; 2015 Jul; 26(3):208-13. PubMed ID: 25686395
[TBL] [Abstract][Full Text] [Related]
8. Predictive model for the preoperative assessment and prognostic modeling of lymph node metastasis in endometrial cancer.
Asami Y; Hiranuma K; Takayanagi D; Matsuda M; Shimada Y; Kato MK; Kuno I; Murakami N; Komatsu M; Hamamoto R; Kohno T; Sekizawa A; Matsumoto K; Kato T; Yoshida H; Shiraishi K
Sci Rep; 2022 Nov; 12(1):19004. PubMed ID: 36347927
[TBL] [Abstract][Full Text] [Related]
9. Cervical invasion, lymphovascular space invasion, and ovarian metastasis as predictors of lymph node metastasis and poor outcome on stages I to III endometrial cancers: a single-center retrospective study.
Li M; Wu S; Xie Y; Zhang X; Wang Z; Zhu Y; Yan S
World J Surg Oncol; 2019 Nov; 17(1):193. PubMed ID: 31733657
[TBL] [Abstract][Full Text] [Related]
10. Lymphovascular space involvement is the sole independent predictor of lymph node metastasis in clinical early stage endometrial cancer.
Vaizoglu F; Yuce K; Salman MC; Basaran D; Calis P; Ozgul N; Usubutun A
Arch Gynecol Obstet; 2013 Dec; 288(6):1391-7. PubMed ID: 23764931
[TBL] [Abstract][Full Text] [Related]
11. Lymph-vascular space invasion and number of positive para-aortic node groups predict survival in node-positive patients with endometrial cancer.
Watari H; Todo Y; Takeda M; Ebina Y; Yamamoto R; Sakuragi N
Gynecol Oncol; 2005 Mar; 96(3):651-7. PubMed ID: 15721407
[TBL] [Abstract][Full Text] [Related]
12. The preoperative serum CA125 can predict the lymph node metastasis in endometrioid-type endometrial cancer.
Ünsal M; Kimyon Comert G; Karalok A; Basaran D; Turkmen O; Boyraz G; Tasci T; Koc S; Boran N; Tulunay G; Turan T
Ginekol Pol; 2018; 89(11):599-606. PubMed ID: 30508211
[TBL] [Abstract][Full Text] [Related]
13. Preoperative CA125 and fibrinogen in patients with endometrial cancer: a risk model for predicting lymphovascular space invasion.
Zhou X; Wang H; Wang X
J Gynecol Oncol; 2017 Mar; 28(2):e11. PubMed ID: 27894164
[TBL] [Abstract][Full Text] [Related]
14. Is Substantial Lymphovascular Space Invasion Prognostic for Clinical Outcomes in Type II Endometrial Cancer?
Jaishankar S; Pifer PM; Bhargava R; Keller A; Musunuru HB; Patel AK; Sukumvanich P; Boisen M; Berger JL; Taylor S; Courtney-Brooks M; Olawaiye A; Lesnock J; Edwards R; Vargo JA; Beriwal S
Clin Oncol (R Coll Radiol); 2022 Jul; 34(7):452-458. PubMed ID: 35264314
[TBL] [Abstract][Full Text] [Related]
15. Systemic Immune-Inflammatory Index as a Predictor of Lymph Node Metastasis in Endometrial Cancer.
Lei H; Xu S; Mao X; Chen X; Chen Y; Sun X; Sun P
J Inflamm Res; 2021; 14():7131-7142. PubMed ID: 34992410
[TBL] [Abstract][Full Text] [Related]
16. A preoperative risk-scoring system to predict lymph node metastasis in endometrial cancer and stratify patients for lymphadenectomy.
Imai K; Kato H; Katayama K; Nakanishi K; Kawano A; Iura A; Konnai K; Onose R; Hirahara F; Miyagi E
Gynecol Oncol; 2016 Aug; 142(2):273-7. PubMed ID: 27268220
[TBL] [Abstract][Full Text] [Related]
17. A nomogram prediction model for lymph node metastasis in endometrial cancer patients.
Wang Z; Zhang S; Ma Y; Li W; Tian J; Liu T
BMC Cancer; 2021 Jun; 21(1):748. PubMed ID: 34187416
[TBL] [Abstract][Full Text] [Related]
18. Lymphovascular space invasion is highly associated with lymph node metastasis and recurrence in endometrial cancer.
Hahn HS; Lee IH; Kim TJ; Lee KH; Shim JU; Kim JW; Lim KT
Aust N Z J Obstet Gynaecol; 2013 Jun; 53(3):293-7. PubMed ID: 23600915
[TBL] [Abstract][Full Text] [Related]
19. Impact of depth and extent of lymphovascular space invasion on lymph node metastasis and recurrence patterns in endometrial cancer.
Matsuo K; Garcia-Sayre J; Medeiros F; Casabar JK; Machida H; Moeini A; Roman LD
J Surg Oncol; 2015 Nov; 112(6):669-76. PubMed ID: 26391212
[TBL] [Abstract][Full Text] [Related]
20. Lymphovascular space invasion as a predictive factor for lymph node metastases and survival in endometrioid endometrial cancer - a Swedish Gynecologic Cancer Group (SweGCG) study.
Stålberg K; Bjurberg M; Borgfeldt C; Carlson J; Dahm-Kähler P; Flöter-Rådestad A; Hellman K; Hjerpe E; Holmberg E; Kjølhede P; Marcickiewicz J; Rosenberg P; Tholander B; Åvall-Lundqvist E; Högberg T
Acta Oncol; 2019 Nov; 58(11):1628-1633. PubMed ID: 31373248
[No Abstract] [Full Text] [Related]
[Next] [New Search]